Zobrazeno 1 - 10
of 30
pro vyhledávání: '"M. A. Teplyakova"'
Autor:
A. A. Lyanova, L. Yu. Vladimirova, E. P. Ulyanova, N. A. Abramova, A. E. Storozhakova, I. L. Popova, N. M. Tikhanovskaya, M. A. Teplyakova, L. A. Ryadinskaya, I. A. Udalenkova, E. A. Kalabanova, S. N. Kabanov
Publikováno v:
Южно-Российский онкологический журнал, Vol 3, Iss 4, Pp 40-48 (2022)
Purpose of the study. An analysis of changes in the expression of the VEGF neoangiogenic factor in the tumor tissue of patients with squamous cell carcinoma of the oral mucosa receiving targeted therapy with cetuximab and chemotherapy.Patients and me
Externí odkaz:
https://doaj.org/article/aaad8131f37d45919c047248caac54d3
Autor:
L. Yu. Vladimirova, E. M. Frantsiyants, N. A. Abramova, K. A. Novoselova, V. S. Myagkova, O. V. Katelnitskaya, A. E. Storozhakova, I. L. Popova, S. N. Kabanov, N. M. Tikhanovskaya, E. A. Kalabanova, L. A. Ryadinskaya, A. A. Lyanova, M. A. Teplyakova, V. R. Zakharchenko, N. K. Guskova
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 9, Iss 3, Pp 25-38 (2022)
Purpose of the study. An analysis of parameters of the blood coagulation system in breast cancer patients after coronavirus disease.Materials and methods. 50 breast cancer patients were divided into groups: the main group included 30 patients after c
Externí odkaz:
https://doaj.org/article/11865fec689245e7beb91d9a5389d4d9
Autor:
L. Yu. Vladimirova, N. A. Abramova, A. A. Lyanova, A. E. Storozhakova, I. L. Popova, M. A. Teplyakova, N. M. Tikhanovskaya, L. A. Ryadinskaya, E. A. Kalabanova, S. N. Kabanov, I. A. Udalenkova
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 117-125 (2022)
Introduction. Erythropoietin (EPO) application is a pathogenetic method for anemia correction in cancer patients.The purpose of study. Clinical evaluation of the efficacy and safety of Eralfon® (epoetin alpha) in treatment for anemia in patients wit
Externí odkaz:
https://doaj.org/article/0556a280772a4126b0e98abb8dd6c6c2
Autor:
L. Yu. Vladimirova, I. L. Popova, N. A. Abramova, M. A. Teplyakova, N. M. Tikhanovskaya, A. A. Lianova, A. E. Storozhakova, L. A. Ryadinskaya, S. N. Kabanov, E. A. Kalabanova
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 186-192 (2022)
The development of a new area of antitumor drug therapy, immunotherapy using immune checkpoint inhibitors targeting PD-1/PD-L1, has significantly changed approaches to the treatment of advanced non-small cell lung cancer (NSCLC). Many clinical trials
Externí odkaz:
https://doaj.org/article/85bf927f8c134ebfb917cdabd1d94338
Autor:
L. Yu. Vladimirova, A. Eh. Storozhakova, I. L. Popova, S. N. Kabanov, N. A. Abramova, M. A. Teplyakova, N. M. Tikhanovskaya, K. A. Novoselova, A. A. Lyanova, L. A. Ryadinskaya, V. S. Myagkova, F. V. Alieva, E. A. Kalabanova, Ya. V. Svetitskaya, N. Yu. Samaneva, A. V. Tishina
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 64-74 (2021)
The development of a new direction in anticancer medical therapy – the use of immune checkpoint inhibitors targeting PD-1/ PD-L1 and CTLA-4 – has significantly changed the approach to tumor treatment in the last few years. The PD1 blocker nivolum
Externí odkaz:
https://doaj.org/article/d6b80369b6694d488584cf1468b3b89e
Autor:
L. Yu. Vladimirova, I. L. Popova, N. A. Abramova, M. A. Teplyakova, N. M. Tikhanovskaya, K. A. Novoselova, A. A. Lyanova, L. A. Ryadinskaya, M. O. Ezhova, V. S. Myagkova, L. K. Strakhova
Publikováno v:
Медицинский совет, Vol 0, Iss 20, Pp 174-180 (2020)
Patients with brain metastases of HER2-positive breast cancer (BC) is a special group of patients who are difficult to treat and have a short life expectancy. The possibilities of whole brain radiotherapy, stereotactic radiosurgery and surgery in suc
Externí odkaz:
https://doaj.org/article/6d970e6a5832433599613d0b310d09d8
Autor:
A. A. Lyanova, L. Yu. Vladimirova, E. P. Ulianova, A. E. Storozhakova, N. A. Abramova, I. L. Popova, M. A. Teplyakova, N. M. Tikhanovskaya, V. S. Myagkova, K. A. Novoselova, L. A. Ryadinskaya, L. K. Strakhova, E. A. Kalabanova
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 182-189 (2020)
Introduction: Squamous cell carcinoma of the oral cavity is one of the most common head and neck cancers with an aggressive course and high mortality rates. The aim of the study was to determine the EGFR expression levels in tumor tissues in patients
Externí odkaz:
https://doaj.org/article/e9073905fe864446ba042d2517c62398
Autor:
L. Yu. Vladimirova, I. L. Popova, N. A. Abramova, A. E. Storozhakova, N. M. Tikhanovskaya, K. A. Novoselova, A. A. L’yanova, L. A. Ryadinskaya, M. O. Ezhova, M. A. Teplyakova, L. K. Strakhov
Publikováno v:
Медицинский совет, Vol 0, Iss 19, Pp 58-64 (2019)
Background. Metastatic breast cancer is still an incurable disease, and is currently regarded as a chronic process requiring longterm treatment with periodic therapy replacements. Hormonal therapy shows its therapeutic efficacy with less toxicity and
Externí odkaz:
https://doaj.org/article/f3f4efc2f21a4a2da78ab4fa835e40be
Autor:
L. Yu. Vladimirova, K. A. Novoselova, N. A. Abramova, I. L. Popova, N. M. Tikhanovskaya, L. A. Ryadinskaya, A. A. Lyanova, M. O. Ezhova, M. A. Teplyakova, A. A. Tishina, E. V. Prikhodko
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 81-86 (2019)
The authors analysed the efficacy and safety of Nab-paclitaxel (Nab-R) monotherapy in patients with metastatic breast cancer with visceral crisis (VC) in the second- and further-line chemotherapy. The objective response rate (ORR) was 35.3% (6 of 17
Externí odkaz:
https://doaj.org/article/f6bd34b143c94a7f9e43c94e117034e2
Autor:
M. D. Khabib, M. Yu. Teplyakova
Publikováno v:
Вестник университета, Vol 1, Iss 11, Pp 33-41 (2022)
The article highlights approaches to assessing the state of the material and technical base of Russian science. The system of indicators used by Russian statistics on the basis of reports collected by the Federal State Statistics Service is considere
Externí odkaz:
https://doaj.org/article/f5fef959538246f7b916d45224cf8359